Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Batas Pemasukan
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 15.74B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Batas Pemasukan
Perubahan
Tanggal
Agilent
USD 362M
23M
2026-06
Align Technology
USD 108.29M
4.48M
2026-06
Bio Techne
USD 51.05M
13.04M
2026-03
Bio-Rad Laboratories
USD 371.4M
898.5M
2026-06
Bruker
USD -62.9M
66.4M
2026-06
Celltrion
KRW 8.82B
64.74M
2026-03
Charles River Laboratories
USD -1.48M
13.36M
2026-06
Cspc Pharmaceutical
CNY 370.72M
592.81M
2025-12
Danaher
USD 870M
159M
2026-06
Dentsply International
USD 37M
47M
2026-06
Deva Holding AS
TRY 583.98M
319.1M
2023-09
Dianthus Therapeutics
USD -40.83M
23.6M
2026-03
Divis Laboratories Ltd
INR 9.02B
1.51B
2026-06
Edwards Lifesciences
USD 241.9M
138.8M
2026-06
Illumina
USD 207M
73M
2026-06
Intuitive Surgical
USD 818.1M
3.4M
2026-06
IQVIA Holdings
USD 256M
18M
2026-06
Kangmei Pharma
CNY -16.56M
12.74M
2026-03
Knight Therapeutics
CAD -3.79M
8.83M
2025-09
Laboratorios Farma
EUR 103.69M
37.04M
2023-12
Laboratory Of America
USD 298.7M
20.9M
2026-06
Malin Corporation
EUR -1.1M
2.2M
2023-12
Medical Developments International
AUD -226K
121K
2025-12
Mesa Laboratories
USD -1.68M
5.1M
2024-12
Mettler Toledo International
USD 232.9M
63.44M
2026-06
Myriad Genetics
USD -7.9M
19.5M
2025-12
Neuren Pharmaceuticals
AUD 15.4M
7.88M
2025-12
OraSure Technologies
USD -19.29M
5.57M
2025-12
Organigram Holdings
CAD -921K
20.89M
2026-03
Ovoca Bio
EUR 4.42M
5.19M
2025-12
Pacific Biosciences Of California
USD -40.37M
2.37M
2025-12
Pharma Mar
EUR -972K
2.5M
2026-06
Qiagen NV
USD 103.4M
35.36M
2026-06
Quest Diagnostics
USD 320M
69M
2026-06
Quidel
USD -92.9M
1.1M
2026-06
Repligen
USD 5.01M
3.32M
2026-06
Revvity
USD 51.82M
11.1M
2026-06
Sartorius
EUR 65.9M
9.7M
2026-06
Sino Biopharmaceutical
CNY 3.39B
2.91B
2025-06
Thermo Fisher Scientific
USD 1.74B
85M
2026-06
Tilray
USD -44.93M
44.61M
2025-09
Waters
USD -136M
64M
2026-06
Zealand Pharma A/S
-394M
14.88M
2026-03
Zz Pientze Pharmaceu
CNY 349.49M
393.99M
2026-06
×